Medifast, Inc. (MED) is a publicly traded Consumer Cyclical sector company. As of September 23, 2026, MED trades at $12.11 with a market cap of $137.08M and a P/E ratio of -5.20. MED moved -1.47% today. Year to date, MED is +13.11%; over the trailing twelve months it is -15.64%. Its 52-week range spans $9.22 to $16.66. Analyst consensus is neutral with an average price target of $12.00. Rallies surfaces MED's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for MED, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $12.11 |
| Market Cap | $137.08M |
| P/E Ratio | -5.20 |
| EPS | $-2.33 |
| Dividend Yield | 1.65% |
| 52-Week High | $16.66 |
| 52-Week Low | $9.22 |
| Volume | 63.17K |
| Avg Volume | 0 |
| Revenue (TTM) | $316.93M |
| Net Income | $-25.60M |
| Gross Margin | 69.24% |
1 analysts cover MED: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $12.00.